TickerFacts.

Solventum Corp (SOLV): Operating Cash Flow

Annual figures by period end, from SEC filings.

$369.00M
Year ended 2025-12-31
$209.00M
Trailing 12 months to 2026-06-30
-39.7%
3-year compound annual growth
$1.92B2022-12-31: $1.68B2023-12-31: $1.92B2024-12-31: $1.19B2025-12-31: $369.00M$369.00M
2022-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$369.00M-68.9%2026-02-27, From 2025-01-01
2024-12-31$1.19B-38.1%2026-02-27, From 2024-01-01
2023-12-31$1.92B+14.1%2026-02-27, From 2023-01-01
2022-12-31$1.68Bn/a2025-02-28, From 2022-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Solventum Corp (SOLV)2025-12-31$369.00M-68.9%
Baxter International Inc (BAX)2025-12-31$845.00M-17.1%
ResMed Inc (RMD)2026-06-30$1.81B+3.1%
Dexcom Inc (DXCM)2025-12-31$1.44B+45.6%
Boston Scientific Corp (BSX)2025-12-31$4.53B+32.0%
Becton Dickinson & Co (BDX)2025-09-30$3.43B-10.8%
MiniMed Group, Inc. (MMED)2026-04-24-$197.00Mn/m
West Pharmaceutical Services Inc (WST)2025-12-31$754.80M+15.5%
Globus Medical Inc (GMED)2025-12-31$753.45M+44.7%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗